China Dominates APAC’s Emergence As Global Trials Hub

39% Of Total Trial Starts In ’23

 
• By Ian Haydock
  
APAC
China dominates APAC clinical trials activity • Source: Shutterstock

More from Global Vision

More from Market Intelligence